Investments in digital therapeutics grew nearly three-fold in 2021 from 2020. Meanwhile VC dollars are also pouring into AI, psychedelics as well as faith-based for-profit apps, which attracted $175.3 million in venture funding in 2021. What’s the efficacy of these new tools and treatments?
Panel: Ben Lewis, co-founder and CEO, Limbix; Nanea Reeves, founder and CEO, Tripp; Mainul Mondal, Founder & CEO, Ellipsis Health.
Thank you to our sponsors: Advsr, a boutique M&A advisory firm; Stratpoint, an outsourced engineering firm; Scrubbed, an online bookkeeping firm; Excelerate, a community-powered business scaling networking
